Detalhe da pesquisa
1.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611196
2.
Is this really thalassemia?
Am J Hematol
; 98(11): 1814-1815, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932887
3.
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Blood
; 117(2): 403-11, 2011 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940414
4.
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies.
Haematologica
; 97(2): 213-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993675
5.
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.
Pharmaceutics
; 14(8)2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36015302
6.
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience.
Blood
; 120(25): 5084-5, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243156
7.
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available.
Leuk Lymphoma
; 60(14): 3493-3502, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359808
8.
From the observation of atypical cells on blood smear to the diagnosis of mast cell leukemia: a case report in a 79 year old woman consulting for anemia.
Ann Biol Clin (Paris)
; 75(6): 689-694, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043985
9.
Thawed autologous peripheral blood stem cells require modified quantification methods for hematopoietic progenitor cell evaluation.
Biomed Mater Eng
; 22(1-3): 57-67, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22766703
10.
PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients.
Leuk Res
; 36(11): 1365-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871473
11.
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.
Leuk Res
; 35(11): 1444-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21715006
12.
Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Genes Chromosomes Cancer
; 45(6): 575-82, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16518848